bpc 157 peter attia 387 - AMA #83: Peptides—evaluating the science, safety, and hype in a rapidly growing field - The Drive - Private Subscriber Feed (🔓) Ask Me Anything (AMA) Archives

PubMed Malinda, K.M., Sidhu, G.S., Mani, H., Banaudha, K., Maheshwari, R.K., Goldstein, A.L., & Kleinman, H.K

FDA's Official Reasons: Lack of Clinical Trials: The FDA emphasizes the need for extensive, controlled clinical trials, which are currently lacking

This positive charge interacts with the acidic environment of the stomach, effectively creating a local buffer zone around the peptide

Finally, as the presented evidence shows, controlling/modulating angiogenesis [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40] should occur along with similar corresponding controlling/modulating of NO-system functioning [11,29,92,93,94,97,98,99] (see below, Section 3)